Dutch-based Pie Medical Imaging has introduced version 2.0 of its CAAS Qardia echocardiography software platform worldwide.
The latest generation of CAAS Quardia is a zero-footprint package that features artificial intelligence (AI)-based workflows for performing key clinical measurements, according to the vendor. It can also provide off-cart echocardiography analysis, including myocardial strain analysis of left and right ventricles as well as assessment of stress-echocardiography, diastology, and proximal isovelocity surface area (PISA) valve scores. The software then automatically generates a report, Pie said.
CAAS Qardia, which has received U.S. Food and Drug Administration clearance and the CE Mark, is available in either a server-based or classical standalone setup, Pie said.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
